We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
3826
DELISTED
ViewRay, Inc.
VRAY
| $115K | ﹤0.01% |
39,863
-15,723
| -28% | -$93.2K |
|
|
ONDK
3827
DELISTED
On Deck Capital, Inc.
ONDK
| $115K | ﹤0.01% |
34,126
+885
| +3% | +$3.15K |
|
3828
Solid Biosciences
SLDB
$794M
| $114K | ﹤0.01% |
+733
| New | +$82.9K |
|
3829
Minerva Neurosciences
NERV
$185M
| $113K | ﹤0.01% |
1,827
-416
| -19% | -$23.6K |
|
|
OPTN
3830
DELISTED
OptiNose
OPTN
| $108K | ﹤0.01% |
+1,032
| New | +$103K |
|
3831
Enel Chile
ENIC
$6.14B
| $107K | ﹤0.01% |
25,480
+5,180
| +26% | +$22.7K |
|
3832
Globalstar
GSAT
$10.7B
| $107K | ﹤0.01% |
17,295
-80
| -0.5% | -$504 |
|
|
ADMS
3833
DELISTED
Adamas Pharmaceuticals
ADMS
| $107K | ﹤0.01% |
+20,995
| New | +$130K |
|
3834
ProQR Therapeutics
PRQR
$243M
| $106K | ﹤0.01% |
18,390
+2,240
| +14% | +$17.9K |
|
3835
Ring Energy
REI
$315M
| $106K | ﹤0.01% |
64,413
-140
| -0.2% | -$300 |
|
|
DSKE
3836
DELISTED
Daseke, Inc. Common Stock
DSKE
| $105K | ﹤0.01% |
41,950
+2,171
| +5% | +$6.1K |
|
3837
CALL
Bloom Energy
BE
$60.6B
| $103K | ﹤0.01% |
+31,600
| New | +$236K |
|
3838
Barclays
BCS
$92.7B
| $102K | ﹤0.01% |
13,806
-90,191
| -87% | -$652K |
|
3839
Inseego
INSG
$114M
| $102K | ﹤0.01% |
+2,126
| New | +$98.9K |
|
|
TNAV
3840
DELISTED
Telenav Inc.
TNAV
| $102K | ﹤0.01% |
+21,386
| New | +$180K |
|
|
TLRA
3841
DELISTED
Telaria, Inc.
TLRA
| $101K | ﹤0.01% |
+14,719
| New | +$122K |
|
3842
Ultrapar
UGP
$6.95B
| $99K | ﹤0.01% |
22,198
-59,238
| -73% | -$279K |
|
|
AGNT
3843
AGNT Inc
AGNT
$666M
| $97K | ﹤0.01% |
23,180
-3,862
| -14% | -$18.3K |
|
3844
Noodles & Co
NDLS
$111M
| $97K | ﹤0.01% |
2,154
+872
| +68% | +$46.8K |
|
|
SUPV
3845
Grupo Supervielle
SUPV
$828M
| $95K | ﹤0.01% |
29,546
-10,709
| -27% | -$55.9K |
|
|
TTSH
3846
DELISTED
Tile Shop Holdings
TTSH
| $95K | ﹤0.01% |
29,987
-1,052
| -3% | -$3.21K |
|
|
FPRX
3847
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $95K | ﹤0.01% |
24,513
-7,849
| -24% | -$43.1K |
|
|
NETI
3848
DELISTED
Eneti Inc.
NETI
| $94K | ﹤0.01% |
1,678
+416
| +33% | +$23.3K |
|
|
IVC
3849
DELISTED
Invacare Corporation
IVC
| $94K | ﹤0.01% |
+12,547
| New | +$70.4K |
|
3850
SIGA Technologies
SIGA
$235M
| $92K | ﹤0.01% |
18,044
+7,323
| +68% | +$39.5K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.